Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthrit...

por Svedbom, Axel, Storck, Chiara, Kachroo, Sumesh, Govoni, Marinella, Khalifa, Ahmed
Publicado 2017

Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and...

por Weinstein, Cindy L J, Meehan, Alan G, Govoni, Marinella, Lin, Jianxin, Reinisch, Walter
Publicado 2023

Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and an...

por Weinstein, Cindy L. J., Meehan, Alan G., Lin, Jianxin, Briscoe, Steven D., Govoni, Marinella
Publicado 2023

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review

por Luttropp, Karin, Dozier, Mary, Justo, Nahila, Cornillie, Freddy, Kachroo, Sumesh, Govoni, Marinella, Salomonsson, Stina, Black, Christopher M, Khalifa, Ahmed
Publicado 2019

Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab

por Vastesaeger, Nathan, Kutzbach, Abraham Garcia, Amital, Howard, Pavelka, Karel, Lazaro, María Alicia, Moots, Robert J., Wollenhaupt, Jürgen, Zerbini, Cristiano A. F., Louw, Ingrid, Combe, Bernard, Beaulieu, Andre, Schulze-Koops, Hendrik, Dasgupta, Bhaskar, Fu, Bo, Huyck, Susan, Weng, Haoling H., Govoni, Marinella, Durez, Patrick
Publicado 2016